Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-030725

EVP & Chief Strategy Officer gave up 382 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Soffer Gad EVP & Chief Strategy Officer 2018-05-15 Shares withheld for taxes −382 $45.90 $17,534 266,506 D
Loading xslF345X03/doc4.xml…